文献速递美容整形

微创面部年轻化临床试验结局报告异质性:是否需要核心结局集?

Heterogeneity in Clinical Outcomes Reporting in Minimally-Invasive Facial Rejuvenation: Is It Time for a Core Outcomes Set?
PubMed 文献 · Plast Reconstr Surg · 2026-06-15

该系统综述纳入2020–2025年微创面部与颈部年轻化治疗的随机对照试验,共242篇,识别出79种研究者评估量表、69种患者报告结局量表和53种客观结局指标。没有任何研究者报告或患者报告结局在超过40%的试验中使用,且同一治疗部位相同治疗类型的研究间疗效定义存在显著异质性。作者建议开发核心结局集以规范报告。

要点

  • 微创面部年轻化试验结局报告高度异质,缺乏统一标准。
  • 无任何评估量表或患者报告结局在超过40%的试验中使用。
  • 建议建立核心结局集以提升证据合成与临床可比性。

核心结论

  • 微创面部年轻化研究结局报告存在显著异质性,亟需开发核心结局集以规范临床试验报告。

研究设计与样本

  • 系统综述纳入2020–2025年发表的微创面部与颈部年轻化治疗随机对照试验,共242篇。
  • 提取每项研究的研究者评估量表、患者报告结局量表和客观结局指标及其定义。

主要发现

  • 共识别79种研究者评估量表、69种患者报告结局量表和53种客观结局指标。
  • 没有任何研究者报告或患者报告结局在超过40%的试验中被使用。
  • 同一治疗类型应用于同一面部区域的研究间,疗效定义存在显著异质性。
  • 报告指标因地区和资金来源不同而存在差异。

关键数值与推荐

  • 无研究者报告或患者报告结局在超过40%的试验中使用。

临床怎么用

  • 临床解读微创面部年轻化证据时需注意结局指标异质性,避免直接比较不同量表的结果。
  • 开展相关临床试验时应参考核心结局集方向,选择可跨研究汇总的结局指标。

局限性

  • 原文未报告检索数据库、偏倚风险评估方法及异质性定量分析结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Outcome measurement in aesthetic medicine is complicated by subjective definitions of beauty, psychosocial factors, and a lack of standardized assessment metrics. Outcome reporting heterogeneity limits physicians' ability to synthesize results from multiple studies. The purpose of this study was to identify the outcomes and outcome scales used in minimally-invasive facial rejuvenation clinical trials to determine the degree of outcome heterogeneity. METHODS: A systematic review was conducted to identify all randomized control trials published in 2020-2025 focusing on non-operative or minimally-invasive facial and neck rejuvenation treatments. We identified outcome measurements reported in each study, including investigator assessment scales, patient-reported outcome scales, and objective outcomes and metrics. RESULTS: Our search identified 242 articles for inclusion. From these, we identified 79 investigator assessment scales, 69 patient-reported outcome scales, and 53 objective outcomes reported. No investigator-reported or patient-reported outcome was used in greater than 40% of trials, and within studies comparing the same treatment type applied to the same facial region, there existed substantial heterogeneity in definitions of treatment efficacy. Furthermore, differences in reported measures existed between regions and funding sources. CONCLUSIONS: There is substantial heterogeneity in outcomes reporting among facial rejuvenation studies. Clinicians, researchers, and industry stakeholders should strive to develop a core outcome set to ensure that meaningful and consistent outcomes are reported in all clinical trials.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Heiman AJ, McManus BT, Thogarchedu D, et al. Heterogeneity in Clinical Outcomes Reporting in Minimally-Invasive Facial Rejuvenation: Is It Time for a Core Outcomes Set? Plast Reconstr Surg. 2026. PMID: 42296489. doi:10.1097/PRS.0000000000013265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。